RecruitingNCT07478796
Blood-level-guided SSRI treatment for depression in young people and adults
About this title
Read the official source — NCT07478796Medication studyAges 12+Poland
Understand this study
Who could participate?
Listed age limits: from 12 years.
- Listed locations
- PoznanSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 3, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 180
- Sponsor
- Poznan University of Medical Sciences
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Poland
- Age range
- Over 12 Years
- Official registry ID
- NCT07478796
- Official title
Show the full official title
Therapeutic Drug Monitoring-Guided Treatment With Sertraline, or Escitalopram in Hospitalized Adults and Children
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Poznan
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Poznan University of Medical Sciences, a university.
Does this study involve medication?
Yes. The study involves medication, including Fluoxetine, Escitalopram and Sertralin.
Who can participate?
Listed age limits: from 12 years.
Is this study still recruiting?
The registry lists this study as recruiting.
